RS

Ramdas Santu Mokhare

Active Director Director DIN 10262123
DIN 10262123 First appointment Jul 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Ramdas Santu Mokhare

Data last updated:

Ramdas Santu Mokhare is a Director at Arrowmark Pharma Private Limited (since 2023). Arrowmark Pharma Private Limited reported revenue of ₹1.8 Lakh (FY 2024).

DIN 10262123
Primary Designation Director
First Appointment 31 Jul 2023
Oldest Company Age 3 yrs
Largest company Arrowmark Pharma Private Limited · ₹1.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arrowmark Pharma Private Limited U47721MH2023PTC407823
Director31 Jul 20232023₹1.8 Lakh (FY 2024)Active

Board colleagues of Ramdas Santu Mokhare

NameDINCompanyDesignation
Baban Murlidhar Jorvar10262122Arrowmark Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arrowmark Pharma Private Limited
Premium access

Shareholding and investment profile for Ramdas Santu Mokhare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramdas Santu Mokhare

Ramdas Santu Mokhare currently holds 1 directorship: Arrowmark Pharma Private Limited (Director, since 31 Jul 2023, revenue ₹1.8 Lakh (FY 2024)).

Ramdas Santu Mokhare was first appointed on 31 Jul 2023 as Director at Arrowmark Pharma Private Limited.

The current boards of Ramdas Santu Mokhare's companies include Baban Murlidhar Jorvar (Arrowmark Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available